Detalles de la búsqueda
1.
Scoring system for optimal cord blood unit selection for single cord blood transplantation.
Cytotherapy
; 26(3): 286-298, 2024 03.
Artículo
Inglés
| MEDLINE | ID: mdl-38149949
2.
Comparison of fludarabine-based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry-based study.
Am J Hematol
; 99(2): 236-244, 2024 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-38165068
3.
SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer.
J Biol Chem
; 298(3): 101724, 2022 03.
Artículo
Inglés
| MEDLINE | ID: mdl-35157849
4.
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells.
Blood
; 137(5): 624-636, 2021 02 04.
Artículo
Inglés
| MEDLINE | ID: mdl-32902645
5.
[Diffuse large B-cell lymphoma expressing high-level glyceraldehyde 3-phosphate dehydrogenase complicated with hypoglycemia].
Rinsho Ketsueki
; 64(7): 608-613, 2023.
Artículo
Japonés
| MEDLINE | ID: mdl-37544719
6.
Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT.
Ann Hematol
; 99(12): 2927-2937, 2020 Dec.
Artículo
Inglés
| MEDLINE | ID: mdl-32940726
7.
A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.
Blood
; 129(6): 740-758, 2017 02 09.
Artículo
Inglés
| MEDLINE | ID: mdl-27821506
8.
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.
Blood
; 128(2): 297-312, 2016 07 14.
Artículo
Inglés
| MEDLINE | ID: mdl-27247137
9.
Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells.
J Immunol
; 194(3): 911-20, 2015 Feb 01.
Artículo
Inglés
| MEDLINE | ID: mdl-25520398
10.
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy.
Cytotherapy
; 18(10): 1312-24, 2016 10.
Artículo
Inglés
| MEDLINE | ID: mdl-27497700
11.
Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse.
Ann Hematol
; 94(7): 1139-48, 2015 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-25680895
12.
Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens.
Transplant Cell Ther
; 30(3): 318.e1-318.e11, 2024 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-38081416
13.
Clonal hematopoiesis of a novel dic(18;20) clone following allogeneic hematopoietic stem cell transplantation.
Int J Hematol
; 119(1): 80-87, 2024 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-37980303
14.
Lymphopenia following the completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma.
Ann Hematol
; 91(3): 375-82, 2012 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-21811783
15.
Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies.
Bone Marrow Transplant
; 57(2): 243-251, 2022 02.
Artículo
Inglés
| MEDLINE | ID: mdl-34815519
16.
Activated B cells suppress T-cell function through metabolic competition.
J Immunother Cancer
; 10(12)2022 12.
Artículo
Inglés
| MEDLINE | ID: mdl-36543374
17.
Mismatched human leukocyte antigen class II-restricted CD8⺠cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation.
Cancer Sci
; 102(7): 1281-6, 2011 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-21466613
18.
Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease.
Blood
; 114(14): 3113-6, 2009 Oct 01.
Artículo
Inglés
| MEDLINE | ID: mdl-19643987
19.
Efficacy of continuous, daily, oral, ultra-low-dose 200 mg acyclovir to prevent herpes zoster events among bortezomib-treated patients: a report from retrospective study.
Jpn J Clin Oncol
; 41(7): 876-81, 2011 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-21616919
20.
Targeting the αv integrin/TGF-ß axis improves natural killer cell function against glioblastoma stem cells.
J Clin Invest
; 131(14)2021 07 15.
Artículo
Inglés
| MEDLINE | ID: mdl-34138753